Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 4635-4638, August 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilmer, J. L.
Right arrow Articles by Kligerman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilmer, J. L.
Right arrow Articles by Kligerman, A. D.

Effect of Acrolein on Phosphoramide Mustard-induced Sister Chromatid Exchanges in Cultured Human Lymphocytes1

James L. Wilmer2, Gregory L. Erexson3 and Andrew D. Kligerman4

Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709

Although phosphoramide mustard (PM) is generally recognized as being the most genotoxic metabolite of cyclophosphamide (CP), the contribution of acrolein to the cytogenetic toxicity of CP is unclear. Besides covalently binding to DNA, acrolein can inactivate critical proteins necessary for replicative DNA synthesis, RNA transcription, cell membrane integrity, and metabolism of xenobiotic and endogenous substrates. Because enzymatic processes are involved in sister chromatid exchange (SCE) formation and DNA excision repair, we hypothesized that acrolein might modulate SCE induction by PM due to acrolein's high binding affinity for proteins and low molecular weight sulfhydryl compounds. Human mononuclear leukocytes were isolated on a Ficoll-Hypaque density gradient, and 106 cells were inoculated into 1.9 ml of complete medium. T-cells were stimulated to grow with 4 µg concanavalin A/ml, and 5-bromo-2'-deoxyuridine (5 µM) was added 24 h later. The cultures were then treated with PM (0.069 µM) in the absence or presence of diethyl-4'-hydroperoxy-CP (DEHP-CP), an activated acrolein-generating compound, at concentrations of 0.1, 1, or 10 µM for 48 h. Demecolcine (1.35 µM) was added for the final 4 h of culture. PM alone induced about a 2-fold increase in the SCE frequency (PM, 14.1 ± 0.5 (SD) versus control, 7.7 ± 0.4) without cell cycle inhibition or reduced mitotic activity. DEHP-CP induced a concentration-related increase in the SCE frequency of up to 1.6-fold without any significant cell cycle inhibition or lowered mitotic activity. When PM and DEHP-CP were combined, SCE induction was additive for all three DEHP-CP concentrations. Except at the highest molar ratio of DEHP-CP:PM (145:1), there was no evidence of cytotoxicity in the other treatment groups. These results suggest that acrolein has a diminished role in mediating the cytogenetic and cytotoxic effects of CP. In addition, enzymes associated with SCE formation and, by inference, DNA excision repair may not be particularly susceptible to acrolein-induced inactivation.

1 This research was funded by the Chemical Industry Institute of Toxicology, a not-for-profit research institute, and was presented at the Environmental Mutagen Society meeting on April 9–13, 1986, in Baltimore, MD.

2 To whom requests for reprints should be addressed, at Cornell University, Department of Poultry and Avian Sciences, 305 Rice Hall, Ithaca, NY 14853.

3 Present address: Environmental Health Research and Testing, Inc., P.O. Box 12199, Research Triangle Park, NC 27709.

4 Present address: U.S. Environmental Protection Agency, Genetic Toxicology Division, Research Triangle Park, NC 27711.

Received 2/ 5/90. Revised 5/ 3/90.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.